Gatifloxacin Ophthalmic Solution

The U.S. Food and Drug Administration has approved gatifloxacin (Zymar®, Zymaxid™) to treat bacterial cases of pink eye (known medically as conjunctivitis). This condition is characterized by inflammation of the conjunctiva, which is the thin membrane that lines the whites of the eyes and the inner eyelids.
 
Gatifloxacin is available as an ophthalmic solution (eye drop) and is applied to the affected eye two to eight times a day for seven days. The exact course of treatment your healthcare provider recommends will depend on the severity of your infection, among other things.
 
(Click Gatifloxacin for more information on this ophthalmic solution, including how it works, important safety precautions, and side effect to watch for during treatment.)
 
7 Easy Tips for Starting Solids
Referring Pages:
Terms of Use
Advertise with Us
Contact Us
About eMedTV
Privacy Policy
Copyright © 2006-2014 Clinaero, Inc.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.